Reconscious Medical has announced the launch of an updated ketamine telemedicine solution to help patients who are resistant to depression treatments. They work with clients across the state of Colorado with a focus on cutting-edge ketamine telehealth programs.
More information can be found at: https://www.reconsciousmedical.com
With the new service update, more patients are able to benefit from personalized medical expertise and innovative tech solutions for their mental health issues.
Reconscious Medical uses psychedelic-enhanced psychotherapy with virtual sessions to ensure patients can enjoy the most effective healing results.
They believe that the current model of psychopharmacology is failing to achieve its core aims, and seek to provide an alternative solution for Colorado residents. Compounding this is the lack of innovation in the field of mainstream treatments for depression.
Reconscious Medical work with individuals dealing with depression and provide tailored ketamine programs to ensure effective results, even when patients have previously been resistant to depression treatment.
The latest research shows that depression is the second most common mental health disorder in the US. When an individual is suffering from depression, it can have an impact on both their work and home life, so it’s important to find the right treatment solution.
Traditional treatment approaches usually involve medication, cognitive behavioral therapy, and other options. However, some individuals don’t respond to these and seek an alternative source of depression relief.
This is where ketamine therapy can have a big impact on those with treatment-resistant depression. Whether taken intravenously or as a nasal spray, studies show that it can have lasting success.
Additional details are provided at: https://www.reconsciousmedical.com/ketamine-telemedicine or https://g.page/reconsciousmedical?share
The team at Reconscious Medical explains that patients usually see results within 1 to 3 sessions, and follow-up treatments can be arranged to help prolong the impact.
A spokesperson for the treatment center states: “Ketamine is a powerful and rapid-acting antidepressant. Administering ketamine in treatment-resistant depression results in enhanced disposition within 4 hours, reaching the peak at 24 hours. The effect is diminished at 7 days, and most patients relapse within 10 days, although for a significant minority the improvement may last 30 days or longer.”
Interested parties can find out more at: https://www.reconsciousmedical.com/ketamine-assisted-psychotherapy
Release ID: 89044715